Earnings Summary

Astrazeneca Plc’s revenue jumped 5.99% since last year same period to $11416Mn in the Q2 2023. On a quarterly growth basis, Astrazeneca Plc has generated 4.94% jump in its revenue since last 3-months.

Astrazeneca Plc’s net profit jumped 405% since last year same period to $1818Mn in the Q2 2023. On a quarterly growth basis, Astrazeneca Plc has generated 0.83% jump in its net profits since last 3-months.

Astrazeneca Plc’s net profit margin jumped 376.47% since last year same period to 15.93% in the Q2 2023. On a quarterly growth basis, Astrazeneca Plc has generated -3.91% fall in its net profit margins since last 3-months.

Astrazeneca Plc’s earning per share (EPS) estimates for the current quarter stand at 0.9 - a 4.75% jump from last quarter’s estimates.

Astrazeneca Plc’s earning per share (EPS) estimates for the current year stand at 0.9.

Astrazeneca Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2023. This indicates that the Astrazeneca Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Astrazeneca Plc declared 0.47 dividend per share during the earnings announcement for Q3 2023.